prevalence of atrial fibrillation - bryan health...a catheter-based curative approach to atrial...
TRANSCRIPT
10/9/2018
1
Robert Percell, MD, FACC
Cardiac Electrophysiologist,
Bryan Heart Institute
Lincoln, NE
Fluoroless Ablation… relinquishing an old habit
Prevalence of Atrial Fibrillation
3.1 Million + 1 Million
by 2020 <10%
Mission:
Provide better access to those eligible patients for ablation therapy.
Atrial Fibrillation is a Progressive Disease
of patients progress from
Paroxysmal to Persistent AF
within 1 year of diagnosis120%
Nieuwlaat R
Typical ProgressionTypical Progression
10/9/2018
2
Afib Management1
2
Ablation Procedure3
Latest Rhythm Control Strategies
10/9/2018
3
Rate vs. Rhythm Control
Timeline
AFFIRM Study
No survival
advantage of Rate vs.
Rhythm control
2002 2006 20142012
Class
III
Level C
2001
Class II
Level B
Ionescu
Mortality among
patients on rhythm
control gradually
decreased relative
to rate control
Class I
Level
A*
Ghanbari
NSR after RFCA is
associated with 60% reduction in
CV mortality
Society Guidelines for Afib: Ablation
*Class I Level A for PAF with no or minimal heart disease
2010
Wilber
RFCA is superior in
efficacy and safety to AAD
2004
Corley (AFFIRM
sub-analysis)
NSR associated
with 47% reduction
on risk of death
2003
DIAMOND
Study
NSR leads to
significant
reduction in
mortality
2002
10/9/2018
4
Progression of AF less likely with Rhythm Control Strategy
Efficacy of Catheter Ablation vs. AAD therapy
Catheter Ablation vs. AAD Therapy
10/9/2018
5
1. Bunch et al. Patients Treated With Catheter Ablation for Atrial Fibrillation Have Long-Term Rates of Death, Stroke and Dementia Similar to Patients Without Atrial Fibrillation. J Cardiovasc
Electrophysiol, Vol. 22, pp. 839-845, August 2011
RF Catheter Ablation Lowers the Risk of Death, Stroke and Dementia 1
Afib Management1
2
Ablation Procedure3
Latest Rhythm Control Strategies
1. Source: Adapted from Calkins H, Brugada J, Packer DL et al. (2007) HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for
personnel, policy, procedures and follow-up. A report of the HRS Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the EHRA and the ECAS; in collaboration with ACC, AHA, and the STS. Endorsed and approved by the governing bodies of the ACC, AHA, ECAS, EHRA, STS, and the HRS. Europace 9(6):335-379.
RF Catheter Ablation Involves Lesion Creation to Prevent Abnormal Activation
• RF catheter ablation uses high frequency
alternating current to eliminate or alter the
arrhythmogenic substrate
• An ablation catheter is used to apply RF to the
endocardium to produce continuous lesions (scars)
that prevent the abnormal electrical activation
contributing to AF
• The most common lesion sets include circling of the
pulmonary veins (PVs) called circumferential PV
isolation
1
10/9/2018
6
TactiCath® - Integration with the PRECISION
Mapping System allows the physician to select,
visualize, and manage ablation parameters
VS
CRYO - No mapping system used. Physician is
limited to only anatomical approach without ability
to diagnose/treat additional arrhythmias Heart
Wall
Last Week’s CaseLast Week’s Case
CTI
54 yo man w/ Persistent Atrial fibrillation, Symptomatic, s/p failed CV,
propafenone
PVI
THERMOCOOL® Catheters (including ThermoCool® SmartTouch® catheter) are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® Systems (excluding NAVISTAR®
RMT THERMOCOOL® Catheter) #021458
Left Atrium Pre PVI
10/9/2018
7
THERMOCOOL® Catheters (including ThermoCool® SmartTouch® catheter) are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® Systems (excluding NAVISTAR®
RMT THERMOCOOL® Catheter) #021458
PVI with Roof and Posterior Floor Line
THERMOCOOL® Catheters (including ThermoCool® SmartTouch® catheter) are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® Systems (excluding NAVISTAR®
RMT THERMOCOOL® Catheter) #021458
Left Atrium Post PVI
THERMOCOOL® Catheters (including ThermoCool® SmartTouch® catheter) are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® Systems (excluding NAVISTAR®
RMT THERMOCOOL® Catheter) #021458
Left Atrium Pre Cryo PVI
10/9/2018
8
THERMOCOOL® Catheters (including ThermoCool® SmartTouch® catheter) are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® Systems (excluding NAVISTAR®
RMT THERMOCOOL® Catheter) #021458
Left Atrium Post Cryo PVI
THERMOCOOL® Catheters (including ThermoCool® SmartTouch® catheter) are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® Systems (excluding NAVISTAR®
RMT THERMOCOOL® Catheter) #021458
AVNRT Ablation
Pulmonary Vein Isolation History
First PVI in Humans 1994
• 12 hours
• 6 hours of X Ray Radiation• Swartz JF, Pellersels G, Silvers J, Patten L, Cervantez D. A catheter-based curative approach to atrial fibrillation in humans (abstract) Circulation. 1994;90:I-335.
•Popularized in 1998
• 6 hour procedure
• 4 hours of X Ray Radiation• Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-
66.
10/9/2018
9
Radiation is NOT NOT NOT NOT your friend
•Discovered in 1896• Wilhelm Roentgen, a German professor of physics
•Harmful effects:• Deterministic
• Dose related effects
• Stochastic
• Dose independent
Harmful Effects of RadiationHarmful Effects of RadiationHarmful Effects of RadiationHarmful Effects of Radiation
• Local erythema
• Cataracts
• Skin desquamation
• Leukopenia
• Atrophy of the organs
• Birth defects
• Multiple organ and bone cancers.
Radiation Exposure
10/9/2018
10
Radiation Burns Post Ablation
Radiation Risks
• It is estimated that with a single dose of 100 mSv
• There is a 1% chance of developing a solid tumor or leukemia
• With a dose as low as 10 mSv
• There is a 0.1% chance of developing cancer.
• Typical EP procedures can deliver between 15–30 mSv and can be as high as 50 mSv in a single setting
• Many EP’s obtain pre procedure CT’s for PV anatomy
• Not to mention wearing 20 lb Lead aprons!
Radiation Free Ablation?
• Case Reports and series
• Pediatrics
• Pregnancy
• “Near Zero”
• Lowering fluoroscopic dose, frame rates, etc.
• Lone single randomized trial with PVI for AF
• Few patients
• All paroxysmal
• Experienced operators
10/9/2018
11
Patient Characteristics
Procedure Times
10/9/2018
12
Safety and Efficacy
Efficacy Results at 3 months
The Journal of Innovations in Cardiac Rhythm Management Zero
Fluoroscopy Radiofrequency Redo Ablation of Atrial Tachycardia after Pulmonary Vein Isolation: A Tale of Two Systems
10/9/2018
13
The Journal of Innovations in Cardiac Rhythm Management Zero Fluoroscopy Radiofrequency Redo Ablation of Atrial
Tachycardia after Pulmonary Vein Isolation: A Tale of Two Systems
Local Activation Time mapping
Sparkle Mapping
10/9/2018
14
SANS FLUORO Ablation numbers
2015 2016 2017 2018 (projected)
0
60
87
105
2
54 52
94
2
132
157
199
SANS FLUORO ABLATIONS
PVI SVT ALL
Future Directions
• Super Obese Patients
• 540 pound patient successful A Flutter ablation
• SANS FLUORO
• Lesion Size Index (LSI)
Questions?